FUSO Pharmaceutical Industries Ltd.

Gene Techno Science has announced an agreement to jointly develop an aflibercept biosimilar version of Eylea with fellow Japanese firm Kishi Kasei. Aflibercept – marketed as a treatment for age-relate

Shares of Kawasaki-based OncoTherapy Science Inc. had plunged by 13.8% in Tokyo in the early afternoon of Jan. 9, the first day of trading after the announcements that following the close of trade

Shionogi has built on its existing licensing alliances with OncoTherapy Science (OTS) to strike a deal that gives it worldwide rights to all future peptide vaccines discovered by the Japanese bioventu

OncoTherapy Science (OTS) will receive an undisclosed milestone payment from Shionogi following a filing by its partner to begin clinical trials with a peptide "cocktail" cancer vaccine. Shionogi is p